These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34654760)

  • 21. Juvenile myelomonocytic leukemia.
    Satwani P; Kahn J; Dvorak CC
    Pediatr Clin North Am; 2015 Feb; 62(1):95-106. PubMed ID: 25435114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia: a way to improve the outcome?
    Niscola P; Cupelli L; Dentamaro T; de Fabritiis P
    Leuk Res; 2016 Mar; 42():80-1. PubMed ID: 26790726
    [No Abstract]   [Full Text] [Related]  

  • 23. Persistence of both cords nine months post double cord blood transplantation for juvenile myelomonocytic leukaemia.
    Yadav SP; Dhingra N; Saxena R; Sachdeva A
    Hematol Oncol Stem Cell Ther; 2013 Jun; 6(2):79-80. PubMed ID: 23669498
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation.
    Ueda S; Sakata N; Muramatsu H; Sakaguchi H; Wang X; Xu Y; Kojima S; Yamaguchi T; Higa T; Takemura T
    Int J Hematol; 2014 Nov; 100(5):502-6. PubMed ID: 25047104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.
    Hecht A; Meyer J; Chehab FF; White KL; Magruder K; Dvorak CC; Loh ML; Stieglitz E
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27948. PubMed ID: 31347788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
    Yoshimi A; Bader P; Matthes-Martin S; Starý J; Sedlacek P; Duffner U; Klingebiel T; Dilloo D; Holter W; Zintl F; Kremens B; Sykora KW; Urban C; Hasle H; Korthof E; Révész T; Fischer A; Nöllke P; Locatelli F; Niemeyer CM;
    Leukemia; 2005 Jun; 19(6):971-7. PubMed ID: 15800672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juvenile myelomonocytic leukemia presenting with features of neonatal hemophagocytic lymphohistiocytosis and cutaneous juvenile xanthogranulomata and successfully treated with allogeneic hemopoietic stem cell transplant.
    Arachchillage DR; Carr TF; Kerr B; Hawkins K; Kelsey A; Judge M; Wynn RF
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):152-5. PubMed ID: 20168243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful second unrelated cord blood transplantation in a child with juvenile myelomonocytic leukemia.
    Alsultan A; Jarrar M; Mushaqbah W; Al-Sudairy R; Jawdat D
    Pediatr Transplant; 2014 Sep; 18(6):651-2. PubMed ID: 24978300
    [No Abstract]   [Full Text] [Related]  

  • 29. Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation.
    Tanoshima R; Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
    Pediatr Blood Cancer; 2008 Mar; 50(3):665-7. PubMed ID: 17437289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy Analysis of Unrelated Cord Blood Transplantation in the Treatment of Juvenile Myelomonocytic Leukemia].
    Cheng SQ; Zhu XY; Tang BL; Liu HL; Yao W; Sun GY; Sun ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1123-1126. PubMed ID: 32798386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute respiratory failure in 3 children with juvenile myelomonocytic leukemia.
    Gustafsson B; Hellebostad M; Ifversen M; Sander B; Hasle H
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e363-7. PubMed ID: 21572349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
    Manabe A
    Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis and treatment of juvenile myelomonocytic leukemia.
    Sakashita K; Matsuda K; Koike K
    Pediatr Int; 2016 Aug; 58(8):681-90. PubMed ID: 27322988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A single-center retrospective study from China.
    Lin YC; Luo CJ; Miao Y; Wang JM; Luo CY; Qin X; Cai JY; Li BS; Chen J
    Pediatr Transplant; 2021 Mar; 25(2):e13825. PubMed ID: 33131184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study.
    Locatelli F; Crotta A; Ruggeri A; Eapen M; Wagner JE; Macmillan ML; Zecca M; Kurtzberg J; Bonfim C; Vora A; Díaz de Heredia C; Teague L; Stein J; O'Brien TA; Bittencourt H; Madureira A; Strahm B; Peters C; Niemeyer C; Gluckman E; Rocha V
    Blood; 2013 Sep; 122(12):2135-41. PubMed ID: 23926304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia.
    Matsuda K; Nakazawa Y; Iwashita C; Kurata T; Hirabayashi K; Saito S; Tanaka M; Yoshikawa K; Yanagisawa R; Sakashita K; Sasaki S; Honda T; Koike K
    Leukemia; 2014 Jul; 28(7):1545-8. PubMed ID: 24496301
    [No Abstract]   [Full Text] [Related]  

  • 37. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study.
    Itonaga H; Iwanaga M; Aoki K; Aoki J; Ishiyama K; Ishikawa T; Sakura T; Fukuda T; Najima Y; Yujiri T; Mori T; Kurokawa M; Nawa Y; Uchida N; Morishita Y; Hashimoto H; Eto T; Hirokawa M; Morishima Y; Nagamura-Inoue T; Atsuta Y; Miyazaki Y
    Leuk Res; 2016 Feb; 41():48-55. PubMed ID: 26754557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained responses after clofarabine-based sequential allogeneic stem cell transplantation in children with high-risk, relapse and/or refractory acute myeloid leukemia or juvenile myelomonocytic leukemia: a study on behalf of the French society of bone marrow transplantation or cell therapy (SFGM-TC).
    Grain A; Sirvent A; Strullu M; Françoise M; Mohty M; Guillaume T; Chevallier P; Rialland F
    Leuk Lymphoma; 2016 Dec; 57(12):2937-2941. PubMed ID: 27184944
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.
    Tüfekçi Ö; Ören H; Demir Yenigürbüz F; Gözmen S; Karapınar TH; İrken G
    Turk J Haematol; 2015 Jun; 32(2):175-9. PubMed ID: 26316488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- mice.
    Krombholz CF; Aumann K; Kollek M; Bertele D; Fluhr S; Kunze M; Niemeyer CM; Flotho C; Erlacher M
    Haematologica; 2016 May; 101(5):597-606. PubMed ID: 26888021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.